Viewing StudyNCT06413680



Ignite Creation Date: 2024-05-19 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06413680
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-22
First Post: 2024-05-09

Brief Title: A First-In Human FIH Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies
Sponsor: Regeneron Pharmaceuticals
Organization: Regeneron Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumors
Melanoma
Clear-Cell Renal-Cell Carcinoma ccRCC
Keywords:
Name View
Primary or secondary resistance to programmed cell death protein 1 PD-1 programmed cell death ligand 1 PD-L1 View
Advanced solid organ malignancies View
Locally advanced View
Metastatic View
Non-uveal View
Unresectable View